Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

Rakon shareholder wants light shed on $400m bid
Markets

Rakon shareholder wants light shed on $400m bid

US giant Skyworks could be Rakon's new owner. One shareholder wants it to confirm.

BNZ ekes out gains in market share as 1H deposits and loans lift
Economy

BNZ ekes out gains in market share as 1H deposits and loans lift

The cost-to-income ratio was 36.2% versus 32.5% in the same period a year earlier.

NZ sharemarket flat amid Tourism Holdings trading halt
Markets Market close

NZ sharemarket flat amid Tourism Holdings trading halt

The S&P/NZX 50 Index closed at 11,874.04, up 6.46 points or 0.05%.

Graham Skellern 02 May 2024